DIAGNOS Announces Results from the Annual Meeting of Shareholders, Appointments of new Chairman and new Chief Medical Officer and Stock Options Grant

BROSSARD, QUEBEC--(Marketwired - Aug. 14, 2017) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK)(OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today results from the votes at the annual general meeting of shareholders ("AGM") held on July 21, 2017, the appointments of Mr. Georges Hébert as Chairman of the board of directors and Dr. Hadi Chakor as Chief Medical Officer and stock options grants to directors and officers.